Which Health-care Professional(s) to Talk About Advance Care Planning ? (QPSPAS)

May 30, 2024 updated by: University Hospital, Grenoble

Which Health-care Professional(s) to Talk About Advance Care Planning ? The Point of View of French Patients Followed in the Context of an Oncological Disease.

The goal of this descriptive observational study is to evaluate the preference of French adult patients followed in the context of a oncological disease, regarding the choice of the preferred healthcare professional to discuss advance care planning.

To this end, voluntary participants will be asked to indicate their preferences by answering a self-questionnaire available in electronic or paper format.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

240

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Grenoble, France
        • Recruiting
        • Chu Grenoble Alpes
        • Contact:
          • Jeremy LASCAUX

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The source population corresponds to the French-speaking population of the Grenoble metropole area, followed in the context of cancer and treated by community medicine and/or healthcare structures.

Description

Inclusion Criteria :

  • Patients with neoplasic disease (under treatment, in exclusive palliative phase, under surveillance or in remission)
  • French-speaking patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
French adult patients followed in the context of a oncological disease,
French-speaking adult patients willing to participate in this study. Patients being treated for oncological disease, in a curative, palliative, or remission phase.
Other: Self-questionnaire
Provision of a self-questionnaire in digital or paper format for the patient. The patient will be asked to indicate their preferences regarding the primary and secondary objectives of the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determining the healthcare professional preferred by cancer patients to talk about advance care planning
Time Frame: Six months
Hierarchical classification of healthcare professionals preferred by the patient via a self-questionnaire
Six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determining cancer patients' second choice of healthcare professional to talk about advance care planning
Time Frame: Six months
Hierarchical classification of health professionals preferred as second choice via a self-questionnaire
Six months
Evaluation of patient preferences regarding advance care planning, concerning the form, the moment it should be carried out, whether or not they wish to be accompanied by a relative, and the benefit of systematization
Time Frame: Six months
Percentage for each response to the questions relating to the modalities of carrying out the interview regarding advance care planning; the most relevant time to discuss advance care planning; the patient's wish to be accompanied or not by a relative at the time of this interview; and the patient's opinion on the relevance of systematically carrying out this interview.
Six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Grenoble

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 19, 2024

Primary Completion (Estimated)

November 1, 2024

Study Completion (Estimated)

November 2, 2024

Study Registration Dates

First Submitted

April 16, 2024

First Submitted That Met QC Criteria

April 16, 2024

First Posted (Actual)

April 19, 2024

Study Record Updates

Last Update Posted (Actual)

June 3, 2024

Last Update Submitted That Met QC Criteria

May 30, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 38RC23.0437
  • 2024-A00485-42 (Other Identifier: ID RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Preference

Clinical Trials on Self-questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe